|
Originally published In Press as doi:10.1074/jbc.M201177200 on May 20, 2002
J. Biol. Chem., Vol. 277, Issue 30, 27501-27509, July 26, 2002
The Carboxyl Terminus of Zona Occludens-3 Binds and Recruits a
Mammalian Homologue of Discs Lost to Tight Junctions*
Michael H.
Roh §,
Chia-Jen
Liu¶,
Stephanie
Laurinec , and
Ben
Margolis ¶ **
From the Howard Hughes Medical Institute, Departments of
Biological Chemistry and ¶ Internal Medicine,
University of Michigan Medical School, Ann Arbor, Michigan 48109
Received for publication, February 5, 2002, and in revised form, April 29, 2002
 |
ABSTRACT |
Mammalian homologues of the
Drosophila polarity proteins Stardust, Discs Lost, and
Crumbs have been identified as Pals1,
Pals1-associated tight
junction protein (PATJ), and human Crumbs homologue 1 (CRB1), respectively. We have previously demonstrated that PATJ, Pals1, and CRB1 can form a tripartite tight junction complex in epithelial cells and that PATJ recruits Pals1 to tight junctions. Here, we observed that the Pals1/PATJ interaction was not crucial for the ultimate targeting of PATJ itself to tight junctions. This prompted us
to examine if any of the 10 post-synaptic density-95/Discs Large/zona
occludens-1 (PDZ) domains of PATJ could bind to the carboxyl termini of
known tight junction constituents. We found that the 6th
and 8th PDZ domains of PATJ can interact with the carboxyl
termini of zona occludens-3 (ZO-3) and claudin 1, respectively. PATJ
missing the 6th PDZ domain was found to mislocalize away
from cell contacts. Surprisingly, deleting the 8th PDZ
domain had little effect on PATJ localization. Finally, reciprocal co-immunoprecipitation experiments revealed that full-length ZO-3 can
associate with PATJ. Hence, the PATJ/ZO-3 interaction is likely important for recruiting PATJ and its associated proteins to tight junctions.
 |
INTRODUCTION |
Polarized epithelia primarily serve to separate and regulate the
movement of ions and metabolites between physiologically distinct
compartments (1, 2). Substances are transported across epithelia mainly
via two mechanisms: the paracellular route, which allow molecules to
cross through spaces existing between epithelial cells, and the
transcellular route, which involve vectorial transport of molecules
through epithelial cells. The latter pathway relies on the demarcation
of the apical and basolateral plasma membranes that are composed of
distinct proteins and lipids. Tight junctions
(TJs)1 are essential for both
pathways in that they serve as selective paracellular barriers
("gates") and "fences" preventing the intermixing of apical and
basolateral membrane constituents (3, 4).
Upon visualization by freeze-fracture electron microscopy, TJs simply
appear as a network of continuous, anastomosing fibrils at the apical
aspect of cell-cell contacts (5). However, the number of proteins known
to compose TJs has grown considerably making it clear that TJs have a
complex molecular architecture (6-8). The first integral membrane
protein found to compose TJs was occludin (9) and it was initially
thought that this protein was responsible for generating TJ fibrils.
However, the claudin family of proteins was shown to be directly
responsible for forming TJ strands (10). Junctional adhesion molecule
(JAM) is another integral membrane protein that has been shown to
co-localize with occludin and claudins to TJs (11, 12).
Although only three distinct classes of integral membrane proteins are
known to exist at TJs, many peripheral membrane TJ proteins have been
identified (3, 8, 13). Some of these interact directly with the
cytoplasmic carboxyl-terminal tails of occludin, claudins, and/or JAM.
For instance, three members of the membrane-associated guanylate kinase
(MAGUK) family, ZO-1, ZO-2, and ZO-3, are known to bind the last
150 residues of occludin (14-16). They also interact via their first
PSD-95/Discs Large/ZO-1 (PDZ) domain with the extreme carboxyl termini
of claudins, most of which end in YV (17). These MAGUK proteins also
interact with the cortical actin cytoskeleton allowing for the
tethering of the TJ fibrils to F-actin (7). Interestingly, although the extreme carboxyl terminus of ZO-1 does not conform to any known PDZ
binding consensus sequence, ZO-2 and ZO-3 terminate in TEL and TDL,
respectively. These carboxyl termini fit the class I PDZ ligand
consensus sequence, (S/T)X(V/I/L)-COOH, where X
represents any amino acid (18). To date, there are no reports
describing the PDZ domain proteins that interact with the carboxyl
termini of ZO-2 and ZO-3.
Recently, two TJ complexes involved in the establishment and/or
maintenance of epithelial cell polarity have been described (19).
First, the Par-6·ASIP·aPKC complex was shown to be important for the formation of TJs (20-23). This complex is conserved in Drosophila (DPar-6/Bazooka/DaPKC) and Caenorhabditis
elegans (Par-6/Par-3/aPKC). The other polarity complex consists of
the mammalian homologues of Drosophila Stardust, Discs Lost,
and Crumbs: Pals1, Pals1-associated tight junction protein (PATJ), and
human Crumbs homologue 1 (CRB1), respectively. Fly embryos missing
Discs Lost, Stardust, or Crumbs fail to form polarized epithelia
during development and fail to progress to adulthood (24, 25). We
recently reported that PATJ, Pals1, and CRB1 can form a ternary complex
at TJs (26).
PATJ was isolated based on its ability to bind and recruit the MAGUK
protein, Pals1, to TJs. PATJ consists of an amino-terminal MAGUK
recruitment (MRE) domain followed by 10 PDZ domains. The MRE domain of
PATJ interacts specifically with Pals1 and is directly responsible for
targeting Pals1 to TJs (26). Nonetheless, it was unclear as to the
exact domain(s) that contributes to the proper targeting of PATJ itself
to TJs. PATJ is a paralogue of multiple PDZ protein 1 (MUPP1), a
protein containing a single MRE domain and 13 PDZ domains. Like PATJ,
MUPP1 was reported to localize to TJs based on its association with the
carboxyl termini of JAM and claudins (27). Here, we investigate the PDZ
domain-based protein interactions between PATJ and known TJ
constituents. Furthermore, we extend this analysis to identifying the
domains that are responsible for targeting PATJ to TJs.
 |
EXPERIMENTAL PROCEDURES |
DNA Constructs--
The cloning of full-length PATJ into the
pcDNA3.1( )/HA and pEYFP-N1 vectors has been described previously
(26). The PATJ open reading frame was amplified by PCR and inserted
into the pRK5-Myc vector. The cDNA encoding for PATJ missing its
last two or five PDZ domains was also generated by PCR and cloned into both pcDNA3.1( )/HA and pEYFP-N1. The first 125 residues
(encompassing the MRE domain) were deleted from the pEYFP-N1-PATJ
construct using a previously described method (28). Internal PDZ domain deletions were generated in the pRK5-Myc-PATJ and pEYFP-N1-PATJ constructs in a similar fashion. Specifically, we deleted residues 1065-1156 (PATJ PDZ6), 1239-1315 (PATJ PDZ7), and 1432-1522
(PATJ PDZ8). The DNA encoding the regions of PATJ encompassing the
6th through 7th and the 8th through
10th PDZ domains (PDZ6-PDZ7 and PDZ8-PDZ10, respectively)
were generated by PCR and inserted into pRK5-Myc. The EYFP-PATJ mutant
constructs were used to study the targeting of PATJ mutants in MDCK
cells. The full-length and mutant HA-PATJ and Myc-PATJ constructs were used to transiently express the various PATJ proteins in HEK293 cells
for use in in vitro binding studies.
The pGSTag and pET15b vectors were used to express GST- and
His6-tagged fusion proteins in BL21 bacterial cells,
respectively. Constructs encoding for GST fused to the last 20 amino
acids of human paracellin-1/claudin-16 (PCLN-1), ZO-2, ZO-3, JAM, and
mouse claudin 1 were made using a previously described method (29). DNA
encoding the first 181 amino acids of Pals1 was generated by PCR and
cloned into the pGSTag vector. The DNA encoding residues 1-238 of PATJ
was cloned into both pET15b and pGSTag.
Finally, the carboxyl-terminal vesicular stomatitis viral G protein
(VSVG)-tagged ZO-3 cDNA was subcloned from the pBK-CMV-ZO3 plasmid
(a gift from Erika Wittchen and Bruce Stevenson) into pRK5-Myc using
BamHI and XbaI sites. To remove the VSVG epitope tag, the pBK-CMV-ZO3 plasmid was digested with XhoI and
XbaI. This removes ~100 bp at the 3' end of the ZO3-VSVG
plasmid insert. Two complementary oligos,
5'-TCGAGATGTGGAGTCCTCCGATGA
GGACGGCTATGACTGGGGACCAGCAACAGACCTGTAAT-3' and
5'-CTAGATTACAGGTCTGTTGCTGGTCCCCAGTCATAGCCGTCCTCATCGGAGGACTCCACATC-3' were annealed and subsequently ligated into the digested
pBK-CMV-ZO3 plasmid. The non-tagged ZO-3 cDNA in the resulting
construct was also subcloned into pRK5-Myc using BamHI and
XbaI restriction sites. The sequences of the inserts
in all plasmid constructs were verified by automated sequencing at the
University of Michigan DNA Sequencing Core.
Antibodies--
The affinity purification of rabbit polyclonal
antibodies directed against Pals1 has been described previously (26).
These antibodies were used at 1:500 dilution for immunoblotting
experiments. For generation of anti-PATJ antisera, rabbits were
injected with a GST-PATJ-(1-238) fusion protein. Anti-PATJ
antibodies were affinity purified using an Affi-Gel 10 column (Bio-Rad)
previously coupled to His6-tagged PATJ-(1-238).
The anti-Myc mouse monoclonal antibody (9E10) was used at 1:1,000
dilution for immunoblotting experiments. The mouse anti-hemagglutinin (HA) monoclonal antibody (clone 12CA5), obtained from Roche Molecular Biochemicals, was used for immunoblotting. For immunoprecipitation and
immunoblot detection of EYFP fusion proteins, rabbit polyclonal and
mouse monoclonal anti-EYFP antibodies (CLONTECH)
were used, respectively. Mouse monoclonal anti-ZO1 antibodies used for
immunostaining were obtained from Zymed Laboratories
Inc. Mouse monoclonal anti-ZO-3 antibodies (Chemicon) were used
in immunostaining and immunoprecipitation experiments. Finally,
secondary antibodies conjugated to Alexa Fluor 488, 594, and 647 were
purchased from Molecular Probes, Inc. (Eugene, OR).
Cell Culture and Transfection--
MDCK and HEK293 cells were
grown and propagated in Dulbecco's modified Eagle's medium
(Invitrogen) supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine, and
10% fetal bovine serum. FuGENE 6 was used according to the
manufacturer's instructions to transfect MDCK and HEK293 cells.
48 h after transfection, HEK293 cells were harvested in Triton
lysis buffer (50 mM HEPES, pH 7.5, 10% glycerol, 150 mM NaCl, 1% Triton X-100, 1.5 mM
MgCl2, and 1 mM EGTA) supplemented with 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml
aprotinin, and 10 µg/ml leupeptin. MDCK cells were split into and
grown in selection media containing 600 µg/ml G418.
MDCK clones expressing the various EYFP-PATJ fusion proteins were
isolated and propagated in medium containing 300 µg/ml G418. For immunostaining experiments, wild type MDCK cells and stable MDCK
clones were seeded at high confluency onto Transwell membrane filters
(0.4-µm pore size; Corning Costar Corp.) and grown for 3-5 days.
Immunostaining and Confocal Microscopy--
Immunostaining was
performed as described previously (26, 29). Briefly, MDCK cells grown
on filters were fixed in 4% formaldehyde/PBS for 15-20 min,
permeabilized with 0.1% Triton X-100/PBS, and blocked with 2% goat
serum/PBS. Filters were then excised from their plastic casing and
incubated with primary antibodies in 2% goat serum/PBS (rabbit
anti-PATJ at 1:100, mouse anti-ZO-1 at 1:1000, and mouse anti-ZO-3 at
1:200) overnight at 30 °C in a humidified chamber. After extensive
washes with 2% goat serum/PBS, filters were incubated with
fluorochrome-conjugated secondary antibody (at 1:1,000 dilution in 2%
goat serum/PBS) for 1-2 h at 30 °C. Subsequently, filters were
washed several times with 2% goat serum/PBS and mounted on glass
slides with ProLong antifade reagent (Molecular Probes, Inc.).
Immunofluorescence microscopy was performed at the University of
Michigan Morphology and Image Analysis Laboratory with a Zeiss LSM510
Axiovert 100M inverted confocal microscope (Carl Zeiss, Inc.,
Thornwood, NY).
In Vitro Binding Experiments, Gel Electrophoresis, and
Immunoblotting--
GST pull-down and immunoprecipitation experiments
were performed as described previously (30). Briefly 5 µg of GST
fusion proteins or 5 µg of antibody (immobilized on
glutathione-agarose or Protein A-Sepharose beads, respectively) were
incubated overnight at 4 °C with 293 or MDCK cell lysates.
Precipitated proteins were washed 3 times with cold PBS supplemented
with 10% glycerol, eluted with sample buffer, and resolved on 4-12%
gradient bis-Tris gels using the NuPAGE electrophoresis system
(Invitrogen). Proteins were electrophoretically transferred from the
gels onto nitrocellulose membranes. Membranes were blocked in 5%
bovine serum albumin/TBS for 30 min and then incubated with primary
antibody in 5% bovine serum albumin/TBS for 2 h at room
temperature. After extensive washing with 0.1% Triton X-100/TBS,
membranes were soaked in TBS supplemented with 5% skim milk and
secondary antibody conjugated to horseradish peroxidase. Incubation
with secondary antibody was performed for 1 h at room temperature
or 4 h at 4 °C. Membranes were washed with 0.1% Triton
X-100/TBS and bands were visualized using ECL reagent (Amersham Biosciences).
 |
RESULTS |
Deletion of the MRE Domain of PATJ Does Not Completely Abolish
Targeting of PATJ to TJs--
Recently, we isolated and identified a
novel multiple PDZ domain protein, PATJ, as a binding partner for Pals1
in MDCK cells (26). PATJ contains 10 PDZ domains in tandem (Fig.
1A) and is a paralogue of
MUPP1 that contains 13 PDZ domains. PATJ is the orthologue of Discs
Lost, a Drosophila polarity protein containing 4 PDZ domains
(25). PATJ and MUPP1 contain single amino-terminal MRE domains that are
capable of binding to the L27N domain of Pals1. Discs Lost also
contains an MRE domain that binds to the single L27 domain of the Pals1
orthologue, Stardust (26). MUPP1 was previously shown to localize to
TJs in MDCK cells (27). Likewise, we also demonstrated by confocal
microscopy that an EYFP-PATJ fusion protein expressed in MDCK cells
targets to TJs (26).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Endogenous PATJ localizes to TJs in polarized
MDCK epithelial cells. A, displayed is a schematic
diagram of PATJ consisting of an amino-terminal MAGUK recruitment (MRE)
domain followed by 10 PDZ domains. The bracket denotes the
region of PATJ used to immunize rabbits for the production of anti-PATJ
antisera. B, MDCK cells were immunostained with affinity
purified rabbit anti-PATJ and mouse monoclonal anti-ZO-1 antibodies as
described under "Experimental Procedures." The square
and rectangular panels represent the X-Y dimension of the
Z-series and the X-Z sections (Z-sections), respectively.
|
|
We first sought to verify the subcellular localization of endogenous
PATJ in polarized MDCK cells. Rabbit polyclonal antibodies were raised
against GST fused to the first 238 amino acids of PATJ. Previously, we
showed that this antibody could recognize endogenous PATJ in MDCK cell
lysates (26). Here, we performed immunostaining experiments using this
antibody on fixed, permeabilized MDCK cells. Confocal microscopy
revealed that endogenous PATJ localizes to TJs (Fig.
1B).
The MRE domain of PATJ is responsible for targeting Pals1 to the TJ. We
next wondered if the association between PATJ and Pals1 was important
for localizing PATJ itself to TJs. To address this issue, we expressed
an EYFP-PATJ mutant protein missing the MRE domain (EYFP-PATJ MRE) in
MDCK cells. This protein still localized to TJs albeit with
decreased efficiency (Fig.
2A). As predicted, we could
show in MDCK cells that full-length EYFP-PATJ could
co-immunoprecipitate with endogenous Pals1 (Fig. 2B), which
was previously shown to appear as a ~70-kDa doublet on immunoblots
(26). In contrast, EYFP-PATJ MRE failed to bind Pals1. In Fig.
2B, there was a slight upward shift in mobilities of the
proteins in the immunoprecipitated ("IP") lanes relative to those
in the "Input" lanes. However, we have consistently observed these
molecular weight shifts when immunoprecipitating other proteins and
resolving them using the NuPAGE electrophoresis system. Thus, we
believe that the mobility shifts of the immunoprecipitated proteins in
Fig. 2B represent artifacts attributable to the NuPAGE
bis-Tris gels. Given the above results, we deduced that the PATJ/Pals1
interaction most likely contributes to the stability of PATJ at TJs but
is not crucial for ultimately targeting PATJ to TJs.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 2.
Deleting the MRE domain of PATJ
does not completely abolish the targeting of PATJ to TJs. A,
PATJ missing its MRE domain was fused to enhanced yellow fluorescent
protein (EYFP) and expressed in MDCK cells. EYFP-PATJ MRE
was directly visualized, whereas the TJ marker, ZO-1, was visualized by
indirect immunofluorescence. B, EYFP-PATJ and
EYFP-PATJ MRE were immunoprecipitated (IP) from MDCK
stable cell lines expressing these proteins. Immunoblotting with
affinity purified anti-Pals1 antibody reveals that the endogenous Pals1
doublet co-immunoprecipitates with EYFP-PATJ but not EYFP-PATJ MRE.
Input denotes straight lysate.
|
|
The Carboxyl Terminus of ZO-3 Binds to PATJ in Vitro--
Deleting
the MRE domain of PATJ did not completely affect the localization of
PATJ to TJs. Thus, we hypothesized that one or more of the PDZ domains
were involved in targeting PATJ to TJs. We examined the extreme
carboxyl termini of known TJ constituents to search for TJ proteins
that could bind class I or class II PDZ domains. Those with PDZ binding
consensus sequences were shown in Fig.
3A. The carboxyl termini of
ZO-2, ZO-3, and PCLN-1 (claudin 16) are predicted to bind class I PDZ
domains, nonetheless, the PDZ proteins that bind to them remain
elusive. On the other hand, the carboxyl terminus of JAM interacts with
class II PDZ domains present in proteins such as CASK/mLin-2, ZO-1,
AF-6, and ASIP/Par-3 (12, 31-33).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
The carboxyl terminus of ZO-3 interacts with
PATJ. A, the last 20 amino acids of TJ proteins predicted to
bind class I or class II PDZ domains via their carboxyl termini are
shown. The last 20 residues of human ZO-2, ZO-3,
paracellin-1/claudin-16 (PCLN-1), and JAM were fused to GST and used in
the GST pull-down experiment shown in B. B, GST
fusion proteins were incubated with lysates derived from 293 cells
expressing Myc-PATJ. Bound Myc-PATJ was detected by immunoblotting with
anti-PATJ antibodies. The first 181 residues of Pals1 were also fused
to GST and used in the experiment. GST-Pals1-(1-181) bears the L27N
domain of Pals1 which was previously shown to bind to the amino
terminus of PATJ (26).
|
|
To determine whether any of these four proteins could associate with
PATJ via their carboxyl termini, we fused the last 20 residues of each
protein onto GST and the resulting GST fusion proteins were used in
in vitro binding experiments. GST fused to the carboxyl
terminus of ZO-3 (GST-ZO-3) interacted with PATJ (Fig. 3B).
However, the carboxyl termini of ZO-2, PCLN-1, and JAM clearly failed
to pull down PATJ. We could also show that PATJ binds to a
GST-Pals1-(1-181) fusion protein which contains the L27N domain of
Pals1 (positive control).
Next, we sought to narrow down the region of PATJ that could bind to
the ZO-3 tail. We expressed truncated versions of PATJ in 293 cells and
investigated whether any of these mutants could bind GST-ZO-3. Deleting
the last two PDZ domains of PATJ does not abolish binding to the ZO-3
tail. However, PATJ missing its last five PDZ domains fails to interact
with the carboxyl terminus of ZO-3 (Fig.
4A). We then wondered if these
two truncated PATJ mutants localized to sites of cell contacts.
EYFP-PATJ PDZ (9-10), but not EYFP-PATJ PDZ (6-10), was observed
to localize to cell adhesions (Fig. 4B). This suggests that
PATJ might be recruited to the TJ through its association with ZO-3 and
that the region encompassing the 6th through
8th PDZ domain of PATJ may mediate this targeting.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
The region encompassing the 6th
through 8th PDZ domains of PATJ was responsible for binding
ZO-3 and localizing PATJ to TJs. A, GST- and GST-ZO-3
pull-down experiments were performed utilizing 293 cell lysates
containing HA-PATJ and HA-PATJ missing the last two or five PDZ
domains: HA-PATJ PDZ-(9-10) and HA-PATJ PDZ-(6-10), respectively.
Precipitated proteins were visualized by blotting with anti-HA
antibody. B, EYFP-PATJ PDZ-(9-10) and
EYFP-PATJ PDZ-(6-10) were expressed in MDCK cells and directly
visualized by fluorescence microscopy.
|
|
The Extreme Carboxyl Termini of ZO-3 and Claudin 1 Interact with
PATJ in a PDZ-dependent Fashion--
The above data alone
do not provide unequivocal evidence for the notion that the ZO-3/PATJ
interaction involves PDZ domains. To better understand the nature of
the ZO-3/PATJ association, we sought to determine whether the last
three residues (TDL) of ZO-3 were necessary for ZO-3 to bind PATJ.
Whereas GST-ZO-3 could interact with PATJ, GST-ZO-3 missing its last
three amino acids (GST-ZO-3 TDL) could not (Fig.
5A). Based on Fig.
4A, we suspected that the 6th, 7th,
or 8th PDZ domain of PATJ represented the binding site for
the extreme carboxyl terminus of ZO-3. Therefore, we individually
deleted each of these three PDZ domains and repeated the in
vitro binding assay with GST-ZO-3 and GST-ZO-3 TDL beads. As
expected, GST-ZO-3 TDL beads failed to pull down any of the PATJ
deletion mutants. GST-ZO-3 interacted with both Myc-PATJ PDZ7 and
Myc-PATJ PDZ8 but not with Myc-PATJ PDZ6 (Fig. 5B).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
The extreme carboxyl termini of ZO-3 and
claudin 1 interact with the 6th and 8th PDZ
domains of PATJ, respectively. A, the indicated GST fusion
proteins were incubated with lysates prepared from 293 cells expressing
full-length Myc epitope-tagged PATJ. GST-ZO-3 and
GST-CLDN-1 refer to GST fusion proteins consisting of the
last 20 residues of ZO-3 and claudin 1, respectively.
GST-CLDN-1 YV and
GST-ZO-3 TDL lack the last two and three
residues present in GST-ZO-3 and GST-CLDN-1, respectively.
B, GST-ZO-3 or GST-ZO-3 TDL were incubated with the
indicated PDZ domain deletion PATJ mutants. Bound proteins were
resolved by SDS-PAGE. In A and B, the expressed
PATJ proteins were visualized by immunoblotting with rabbit polyclonal
anti-PATJ. C, GST-CLDN-1 pull-down assays were performed
using lysates containing Myc-PATJ or the indicated Myc-PATJ PDZ
deletion mutants. D, the ability of the indicated GST fusion
proteins to bind two fragments of PATJ (PDZ6-PDZ7 and PDZ8-PDZ10) were
examined. In C and D, the bound PATJ proteins
were resolved by SDS-PAGE and visualized by anti-Myc immunoblot.
|
|
While this study was in progress, it was shown that the
carboxyl-terminal YV sequence of claudin 1 (and presumably many other members of the claudin family) was crucial for the ability of this
protein to bind the 10th PDZ domain of MUPP1 (27). This
domain of MUPP1 is highly similar in sequence to the 8th
PDZ domain of PATJ. In fact, these respective PDZ domains
represent the region of the highest amino acid sequence identity
between MUPP1 and PATJ (26). As the claudin 1 carboxyl terminus was shown to interact with MUPP1, we could also demonstrate that a GST-claudin 1 fusion protein (GST-CLDN1) binds PATJ (Fig.
5A). As expected, the GST-CLDN1 missing the last two amino
acids (GST-CLDN1 YV) failed to interact with PATJ. To further
characterize the interaction between PATJ and claudin 1, we performed
GST-CLDN1 pull downs with Myc-PATJ PDZ6, Myc-PATJ PDZ7, and
Myc-PATJ PDZ8. The GST-CLDN1 fusion protein bound both
Myc-PATJ PDZ6 and Myc-PATJ PDZ7 but failed to interact with
Myc-PATJ PDZ8 (Fig. 5C).
We also investigated the binding between the carboxyl termini of ZO-3
and claudin 1 and two short fragments of PATJ: PDZ6-PDZ7 and
PDZ8-PDZ10. We again observed that the tails of ZO-3 and claudin 1 associate with PATJ at distinct sites as GST-ZO-3 could only bind to a
PDZ6-PDZ7 containing fragment and GST-CLDN1 could only pull down a
fragment of PATJ containing PDZ8-PDZ10 (Fig. 5D). As
expected, both GST-ZO-3 TDL and GST-CLDN1 YV did not significantly interact with either of the two PATJ fragments. Therefore, we conclude
that the extreme carboxyl termini of ZO-3 and claudin 1 interact with
the 6th and 8th PDZ domains of PATJ, respectively.
The 6th PDZ Domain Targets PATJ to TJs--
In Fig.
4B, we show that the region of PATJ encompassing the
6th through 8th PDZ domain was important for
the recruitment of PATJ to cell contacts. Upon closer examination of
the data in Fig. 5, we noticed that the interaction between GST-CLDN1
and PATJ was weaker than that between GST-ZO-3 and PATJ. However, the
relative affinities observed in these in vitro pull-down
assays may not accurately reflect the true affinities between these
proteins in vivo. Thus, we wanted to determine the degree to
which the 6th, 7th, and 8th PDZ
domains each contributed to the targeting of PATJ. We individually deleted these three PDZ domains from EYFP-PATJ and expressed the resulting deletion mutants in MDCK cells. EYFP-PATJ missing the 6th PDZ domain was predominantly mislocalized from cell
contacts (Fig. 6). This was observed in
several clones expressing this protein (results not shown). However,
EYFP-PATJ missing the 7th PDZ domain still co-localized
with ZO-1 to TJs. Surprisingly, deleting the 8th PDZ
domain, which binds to the carboxyl terminus of claudin 1, had little
effect on the targeting of the EYFP-PATJ PDZ8 protein to TJs (Fig.
6). These results suggest that the interaction between claudin 1 and
PATJ may be dispensable in the targeting of PATJ to TJs, whereas that
between ZO-3 and PATJ may be crucial for properly localizing PATJ to
TJs.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 6.
Targeting of PDZ deletion PATJ mutants in
MDCK cells. EYFP-PATJ missing the 6th,
7th, or 8th PDZ domains were expressed in MDCK
cells. The ability of these PATJ mutants to localize to TJs were
studied by immunostaining these cells with anti-ZO-1 antibody
(red). EYFP-PATJ mutant proteins were directly visualized by
fluorescence microscopy (green).
|
|
ZO-3 Co-immunoprecipitates with PATJ in Vitro and Co-localizes with
PATJ to TJs in Vivo--
To determine whether full-length ZO-3 could
form a complex with full-length PATJ, we performed reciprocal
co-immunoprecipitation experiments on lysates derived from 293 cells
expressing Myc-ZO-3 and Myc-PATJ. Anti-ZO-3 monoclonal antibodies and
anti-PATJ antisera were used to immunoprecipitate Myc-ZO-3 and
Myc-PATJ, respectively. On the other hand, the anti-Myc monoclonal
antibody was used to simultaneously detect both proteins. We observed
that PATJ indeed co-precipitates with ZO-3 (Fig.
7A). As a negative control,
the identical co-immunoprecipitations were carried out using 293 lysates containing Myc-PATJ and Myc-ZO-3 containing a carboxyl-terminal VSVG epitope tag (denoted as Myc-ZO-3vsvg). The VSVG tag masks the
extreme carboxyl-terminal PDZ binding TDL sequence of ZO-3. Hence,
Myc-ZO-3vsvg was not expected to bind the PDZ domains. As predicted,
the Myc-ZO-3vsvg protein failed to co-immunoprecipitate with Myc-PATJ
(Fig. 7A). Finally, we were able to demonstrate that
endogenous PATJ and ZO-3 co-localize to TJs in an MDCK epithelial monolayer (Fig. 7B). Collectively, our results indicate that ZO-3 binds
to the 6th PDZ domain of PATJ via its extreme carboxyl
terminus. This interaction is likely important for recruiting PATJ and
its binding partners such as Pals1 to TJs (Fig.
8).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 7.
ZO-3 and PATJ form a complex and co-localize
to TJs in MDCK cells. A, full-length Myc-PATJ was
co-expressed with either Myc-ZO3 or Myc-ZO3 tagged with VSVG at the
carboxyl terminus (Myc-ZO3vsvg). The latter ZO-3 protein no
longer terminates in the TDL sequence and was not predicted to bind a
PDZ domain. Immunoprecipitations with anti-ZO-3 monoclonal antibody,
preimmune serum (Control IP), or PATJ antisera were
performed on the 293 lysates containing the indicated proteins. Bound
proteins were resolved by SDS-PAGE. PATJ and the ZO-3 proteins were
detected simultaneously by immunoblotting with anti-Myc antibody. The
arrowhead and arrow indicate the full-length
Myc-PATJ and the ZO-3 proteins, respectively. The asterisk
corresponds to a background band observed in lysates derived from 293 cells expressing Myc-PATJ. This band was not recognized by anti-PATJ
antibodies (see Anti-PATJ IP lanes and also Fig.
5A). B, MDCK cells were immunostained
simultaneously with rabbit anti-PATJ and mouse anti-ZO-3 antibodies.
Endogenous PATJ and ZO-3 are shown in green and
red, respectively.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 8.
Model depicting the interaction of the
PATJ·Pals1·Crumbs complex with TJ constituents in epithelial
cells. The 6th PDZ domain of PATJ interacts with the
extreme carboxyl-terminal TDL sequence of ZO-3. The 8th PDZ
domain of PATJ binds to the carboxyl termini of members of the claudin
family which end in the YV sequence. The 1st PDZ domain of
ZO-3, as well as ZO-1 and ZO-2 (not shown), also interacts with the
carboxyl-terminal YV sequence of claudins (26). The L27N domain of the
MAGUK protein, Pals1, binds to the amino-terminal MRE domain of
PATJ. In addition, the single PDZ domain of Pals1 binds to the
extreme carboxyl-terminal ERLI sequence of the integral membrane
protein, Crumbs. It was previously shown that PATJ, Pals1, and Crumbs
co-localize to TJs (26). Green crescents represent PDZ
domains and are numbered in order from the amino to carboxyl terminus.
L27, Lin-2/Lin-7 domain; SH3, Src homology 3 domain; GUK, guanylate kinase-like domain.
|
|
 |
DISCUSSION |
We previously showed that a mammalian homologue of
Drosophila Discs Lost, PATJ, can exist in a complex with
mammalian homologues of Stardust (Pals1) and Crumbs (CRB1) at TJs (26).
PATJ contains an amino-terminal MRE domain that mediates the
interaction between PATJ and Pals1. Whereas this interaction was
crucial for properly targeting Pals1 to TJs, we observed that this was
not the case for PATJ (Fig. 2A). In addition, PATJ contains
10 tandemly arranged PDZ domains whose ligands were unknown. We
hypothesized that one or more of these PDZ domains conferred the
ability of PATJ to localize to TJs. Here, we have identified ZO-3 and
claudin 1 as ligands for the 6th and 8th PDZ
domains of PATJ, respectively. Because many claudin family members
terminate in the YV carboxyl-terminal sequence, it seems likely that
other claudins also bind to the 8th PDZ domain of PATJ in
epithelial cells.
MUPP1, a paralogue of PATJ, was also shown to localize to TJs in MDCK
cells (27). MUPP1 contains 13 PDZ domains in tandem and JAM and claudin
1 were identified as binding partners for the 9th and
10th PDZ domains of MUPP1, respectively. The expression of
JAM in non-polarized L cell fibroblasts, which lack endogenous claudins and other cell adhesion molecules, was sufficient for recruiting exogenously expressed MUPP1 to the plasma membrane. This suggests that
in polarized epithelial cells, the JAM/MUPP1 interaction may be
sufficient for and that the claudin/MUPP1 interaction may not be
crucial for recruiting MUPP1 to TJs. Here, we find that in contrast to
MUPP1, PATJ does not bind to the extreme carboxyl terminus of JAM.
Similar to MUPP1, we observe that PATJ can indeed bind the tail of
claudin 1. Furthermore, the 8th PDZ domain of PATJ, which
was highly similar in sequence to the 10th PDZ domain of
MUPP1, was shown to mediate this interaction. Nonetheless, we found
that claudin 1/PATJ association does not contribute to the targeting of
PATJ to TJs as PATJ that was missing the 8th PDZ
domain still localizes properly to TJs. Deleting the 6th
PDZ domain of PATJ, the binding site for the ZO-3 carboxyl terminus, abolishes the targeting of PATJ to TJs. This suggests that the ZO-3/PATJ interaction could be responsible for recruiting PATJ to TJs.
The converse, however, was not true considering that the amino-terminal
half of ZO-3, which lacks the Src homology 3 domain, guanylate
kinase-like domain, and the extreme carboxyl terminus, localizes to TJs
(15). It should also be noted that the 6th PDZ domain of
PATJ is a class I PDZ domain (34). Our observation that the extreme
carboxyl-terminal TDL sequence of ZO-3 binds this PDZ domain was
consistent with that notion.
The PATJ·Pals1·Crumbs and Discs Lost·Stardust·Crumbs complexes
exist just superior to adherens junctions in mammalian and Drosophila epithelia, respectively (19, 26). The
localization of the latter complex to the subapical complex (SAC) was
shown to be crucial for establishment and maintenance of polarity in ectodermally derived epithelia (25, 35-38). In fly embryos lacking Stardust expression, Discs Lost fails to localize to the SAC in epithelial cells established during cellularization (35). In these
embryos, Crumbs also fails to localize properly (36). Therefore,
Stardust seems to be required for the proper recruitment of Crumbs and
Discs Lost to the SAC. In contrast, we find that while the PATJ/Pals1
interaction was necessary for targeting Pals1 to TJs, it does not
seem to be crucial for localizing PATJ itself to TJs. In agreement with
the Drosophila studies, we have also observed that Crumbs
targeting was dependent on its interaction with
Pals1.2 Therefore, in
mammalian epithelia, it appears that the individual components of the
PATJ·Pals1·Crumbs complex could be recruited to TJs in sequential
fashion. Specifically, ZO-3 may function to recruit PATJ to TJs and in
turn PATJ targets Pals1 and Crumbs to TJs.
Interestingly, the Drosophila SAC has been compared with
mammalian TJs because several homologues of known TJ proteins such as
Par-6, aPKC, and ASIP (DPar-6, DaPKC, and Bazooka, respectively) were
known to localize to the SAC (19). Because these three proteins were
shown to play a crucial role in the biogenesis of TJs, the SAC likely
represents the region of the plasma membrane where TJs will form. It
should still be noted that no claudin, occludin, ZO-2, or ZO-3
homologues have been shown to exist within the SAC. The ZO-1 homologue,
Polychaetoid (Pyd), has been recently reported to exist as two
isoforms, one of which localizes to adherens junctions and the other
that displays a broader plasma membrane localization (39). Nonetheless,
the precise relationship between Pyd and the SAC, if there is any,
remains unclear. Neither the carboxyl termini of ZO-1 nor Pyd are
predicted to bind PDZ domains. Collectively, it is tempting to
speculate that the presence of additional PDZ domains in PATJ, relative
to Discs Lost, correlates with its localization to TJs in mammalian epithelia.
Previously, it was reported that the Par-6·ASIP·aPKC polarity
complex was recruited to TJs possibly through the association of the
ASIP PDZ domain and the extreme carboxyl terminus of JAM. Here, we have
provided insight as to how the PATJ·Pals1·Crumbs polarity complex
is localized to TJs as two of the 10 PDZ domains of PATJ were shown to
interact with ZO-3 and claudin 1. It will be interesting to identify
the proteins that bind to the other eight PATJ PDZ domains. Surely,
this will shed more light on how the PATJ·Pals1·Crumbs complex
may function and add to the growing list of molecules that contribute
to the complex molecular architecture of TJs in mammalian epithelial cells.
 |
ACKNOWLEDGEMENTS |
We are grateful to Erika Wittchen and Bruce
Stevenson (University of Alberta) for generously providing the
pBK-CMV-ZO3 plasmid. We also thank the University of Michigan
Morphology and Image Analysis Core for allowing us to use their
confocal microscope.
 |
FOOTNOTES |
*
This work was supported in part by NIDDK, National
Institutes of Health Grant DK58208.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by the Medical Scientist Training Program Grant T32
GM07863 and Predoctoral Genetics Training Program Grant T32 GM07544-24
to the University of Michigan during the course of these studies.
**
Investigator of the Howard Hughes Medical Institute. To whom
corresponding should be addressed: Howard Hughes Medical Inst., University of Michigan Medical Center, 4570 MSRB II, Box 0650, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0650. Tel.: 734-764-3567; Fax:
734-763-9323; E-mail: bmargoli@umich.edu.
Published, JBC Papers in Press, May 20, 2002, DOI 10.1074/jbc.M201177200
2
M. Roh and B. Margolis, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
TJ, tight junction;
CRB, Crumbs;
PATJ, Pals1-associated tight junction;
Pals1, protein
associated with Lin Seven;
PDZ, postsynaptic density 95/discs
large/zona occludens 1;
ZO-3, zona occludens 3;
JAM, junctional adhesion molecule;
MAGUK, membrane-associated guanylate
kinase;
MRE, MAGUK recruitment;
MUPP1, multiple PDZ protein 1;
PCLN, paracellin;
SAC, subapical complex;
MUPP1, multiple PDZ protein 1;
MDCK, Madin-Darby canine kidney;
GST, glutathione
S-transferase;
HA, hemagglutinin;
bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
PBS, phosphate-buffered saline;
TBS, Tris-buffered saline;
VSVG, vesicular
stomatitis viral G protein.
 |
REFERENCES |
| 1.
|
Tsukita, S.,
and Furuse, M.
(2000)
J. Cell Biol.
149,
13-16[Abstract/Free Full Text]
|
| 2.
|
Madara, J. L.
(1998)
Annu. Rev. Physiol.
60,
143-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Zahraoui, A.,
Louvard, D.,
and Galli, T.
(2000)
J. Cell Biol.
151,
F31-F36[Abstract/Free Full Text]
|
| 4.
|
Cereijido, M.,
Valdes, J.,
Shoshani, L.,
and Contreras, R. G.
(1998)
Annu. Rev. Physiol.
60,
161-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Tsukita, S.,
and Furuse, M.
(1998)
Genes Cells
3,
569-573[Abstract]
|
| 6.
|
Mitic, L. L.,
and Anderson, J. M.
(1998)
Annu. Rev. Physiol.
60,
121-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Fanning, A. S.,
Mitic, L. L.,
and Anderson, J. M.
(1999)
J. Am. Soc. Nephrol.
10,
1337-1345[Abstract/Free Full Text]
|
| 8.
|
Lapierre, L. A.
(2000)
Adv. Drug Deliv. Rev.
41,
255-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Furuse, M.,
Hirase, T.,
Itoh, M.,
Nagafuchi, A.,
Yonemura, S.,
and Tsukita, S.
(1993)
J. Cell Biol.
123,
1777-1788[Abstract/Free Full Text]
|
| 10.
|
Furuse, M.,
Sasaki, H.,
Fujimoto, K.,
and Tsukita, S.
(1998)
J. Cell Biol.
143,
391-401[Abstract/Free Full Text]
|
| 11.
|
Martin-Padura, I.,
Lostaglio, S.,
Schneemann, M.,
Williams, L.,
Romano, M.,
Fruscella, P.,
Panzeri, C.,
Stoppacciaro, A.,
Ruco, L.,
Villa, A.,
Simmons, D.,
and Dejana, E.
(1998)
J. Cell Biol.
142,
117-127[Abstract/Free Full Text]
|
| 12.
|
Itoh, M.,
Sasaki, H.,
Furuse, M.,
Ozaki, H.,
Kita, T.,
and Tsukita, S.
(2001)
J. Cell Biol.
154,
491-497[Abstract/Free Full Text]
|
| 13.
|
Gonzalez-Mariscal, L.,
Betanzos, A.,
and Avila-Flores, A.
(2000)
Semin. Cell Dev. Biol.
11,
315-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Wittchen, E. S.,
Haskins, J.,
and Stevenson, B. R.
(1999)
J. Biol. Chem.
274,
35179-35185[Abstract/Free Full Text]
|
| 15.
|
Haskins, J., Gu, L.,
Wittchen, E. S.,
Hibbard, J.,
and Stevenson, B. R.
(1998)
J. Cell Biol.
141,
199-208[Abstract/Free Full Text]
|
| 16.
|
Furuse, M.,
Itoh, M.,
Hirase, T.,
Nagafuchi, A.,
Yonemura, S.,
and Tsukita, S.
(1994)
J. Cell Biol.
127,
1617-1626[Abstract/Free Full Text]
|
| 17.
|
Itoh, M.,
Furuse, M.,
Morita, K.,
Kubota, K.,
Saitou, M.,
and Tsukita, S.
(1999)
J. Cell Biol.
147,
1351-1363[Abstract/Free Full Text]
|
| 18.
|
Songyang, Z.,
Fanning, A. S., Fu, C., Xu, J.,
Marfatia, S. M.,
Chishti, A. H.,
Crompton, A.,
Chan, A. C.,
Anderson, J. M.,
and Cantley, L. C.
(1997)
Science
275,
73-77[Abstract/Free Full Text]
|
| 19.
|
Tepass, U.,
Tanentzapf, G.,
Ward, R.,
and Fehon, R.
(2001)
Annu. Rev. Genet.
35,
747-784[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Yamanaka, T.,
Horikoshi, Y.,
Suzuki, A.,
Sugiyama, Y.,
Kitamura, K.,
Maniwa, R.,
Nagai, Y.,
Yamashita, A.,
Hirose, T.,
Ishikawa, H.,
and Ohno, S.
(2001)
Genes Cells
6,
721-731[Abstract]
|
| 21.
|
Suzuki, A.,
Yamanaka, T.,
Hirose, T.,
Manabe, N.,
Mizuno, K.,
Shimizu, M.,
Akimoto, K.,
Izumi, Y.,
Ohnishi, T.,
and Ohno, S.
(2001)
J. Cell Biol.
152,
1183-1196[Abstract/Free Full Text]
|
| 22.
|
Joberty, G.,
Petersen, C.,
Gao, L.,
and Macara, I. G.
(2000)
Nat. Cell Biol.
2,
531-539[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lin, D.,
Edwards, A. S.,
Fawcett, J. P.,
Mbamalu, G.,
Scott, J. D.,
and Pawson, T.
(2000)
Nat. Cell Biol.
2,
540-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Tepass, U.,
and Knust, E.
(1993)
Dev. Biol.
159,
311-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Bhat, M. A.,
Izaddoost, S., Lu, Y.,
Cho, K. O.,
Choi, K. W.,
and Bellen, H. J.
(1999)
Cell
96,
833-845[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Roh, M. H.,
Makarova, O.,
Liu, C.,
Shin, K.,
Lee, S.,
Laurinec, S.,
Goyal, M.,
Wiggins, R.,
and Margolis, B.
(2002)
J. Cell Biol.
157,
161-172[Abstract/Free Full Text]
|
| 27.
|
Hamazaki, Y.,
Itoh, M.,
Sasaki, H.,
Furuse, M.,
and Tsukita, S.
(2002)
J. Biol. Chem.
277,
455-461[Abstract/Free Full Text]
|
| 28.
|
Makarova, O.,
Kamberov, E.,
and Margolis, B.
(2000)
BioTechniques
29,
970-972[Medline]
[Order article via Infotrieve]
|
| 29.
|
Straight, S. W.,
Chen, L.,
Karnak, D.,
and Margolis, B.
(2001)
Mol. Biol. Cell
12,
1329-1340[Abstract/Free Full Text]
|
| 30.
|
Kamberov, E.,
Makarova, O.,
Roh, M.,
Liu, A.,
Karnak, D.,
Straight, S.,
and Margolis, B.
(2000)
J. Biol. Chem.
275,
11425-11431[Abstract/Free Full Text]
|
| 31.
|
Ebnet, K.,
Suzuki, A.,
Horikoshi, Y.,
Hirose, T.,
Meyer Zu Brickwedde, M. K.,
Ohno, S.,
and Vestweber, D.
(2001)
EMBO J.
20,
3738-3748[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Ebnet, K.,
Schulz, C. U.,
Meyer Zu Brickwedde, M. K.,
Pendl, G. G.,
and Vestweber, D.
(2000)
J. Biol. Chem.
275,
27979-27988[Abstract/Free Full Text]
|
| 33.
|
Martinez-Estrada, O. M.,
Villa, A.,
Breviario, F.,
Orsenigo, F.,
Dejana, E.,
and Bazzoni, G.
(2001)
J. Biol. Chem.
276,
9291-9296[Abstract/Free Full Text]
|
| 34.
|
Vaccaro, P.,
Brannetti, B.,
Montecchi-Palaizz, L.,
Philipp, S.,
Citterich, M. H.,
Cesareni, G.,
and Dente, L.
(2001)
J. Biol. Chem.
276,
42122-42130[Abstract/Free Full Text]
|
| 35.
|
Bachmann, A.,
Schneider, M.,
Theilenberg, E.,
Grawe, F.,
and Knust, E.
(2001)
Nature
414,
638-643[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Hong, Y.,
Stronach, B.,
Perrimon, N.,
Jan, L. Y.,
and Jan, Y. N.
(2001)
Nature
414,
634-638[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Tepass, U.
(1996)
Dev. Biol.
177,
217-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Grawe, F.,
Wodarz, A.,
Lee, B.,
Knust, E.,
and Skaer, H.
(1996)
Development
122,
951-959[Abstract]
|
| 39.
|
Wei, X.,
and Ellis, H. M.
(2001)
Mech. Dev.
100,
217-231[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. S. Balda and K. Matter
Tight junctions at a glance
J. Cell Sci.,
November 15, 2008;
121(22):
3677 - 3682.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Angelow, R. Ahlstrom, and A. S. L. Yu
Biology of claudins
Am J Physiol Renal Physiol,
October 1, 2008;
295(4):
F867 - F876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Duning, E.-M. Schurek, M. Schluter, M. Bayer, H.-C. Reinhardt, A. Schwab, L. Schaefer, T. Benzing, B. Schermer, M. A. Saleem, et al.
KIBRA Modulates Directional Migration of Podocytes
J. Am. Soc. Nephrol.,
October 1, 2008;
19(10):
1891 - 1903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Mee, J. Grove, H. J. Harris, K. Hu, P. Balfe, and J. A. McKeating
Effect of Cell Polarization on Hepatitis C Virus Entry
J. Virol.,
January 1, 2008;
82(1):
461 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Stucke, E. Timmerman, J. Vandekerckhove, K. Gevaert, and A. Hall
The MAGUK Protein MPP7 Binds to the Polarity Protein hDlg1 and Facilitates Epithelial Tight Junction Formation
Mol. Biol. Cell,
May 1, 2007;
18(5):
1744 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Storrs and S. J. Silverstein
PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6
J. Virol.,
April 15, 2007;
81(8):
4080 - 4090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Massey-Harroche, M.-H. Delgrossi, L. Lane-Guermonprez, J.-P. Arsanto, J.-P. Borg, M. Billaud, and A. Le Bivic
Evidence for a molecular link between the tuberous sclerosis complex and the Crumbs complex
Hum. Mol. Genet.,
March 1, 2007;
16(5):
529 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mandicourt, S. Iden, K. Ebnet, M. Aurrand-Lions, and B. A. Imhof
JAM-C Regulates Tight Junctions and Integrin-mediated Cell Adhesion and Migration
J. Biol. Chem.,
January 19, 2007;
282(3):
1830 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G.S.H. van Rossum, W. M. Aartsen, J. Meuleman, J. Klooster, A. Malysheva, I. Versteeg, J.-P. Arsanto, A. Le Bivic, and J. Wijnholds
Pals1/Mpp5 is required for correct localization of Crb1 at the subapical region in polarized Muller glia cells
Hum. Mol. Genet.,
September 15, 2006;
15(18):
2659 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanaka, R. Kamata, and R. Sakai
EphA2 Phosphorylates the Cytoplasmic Tail of Claudin-4 and Mediates Paracellular Permeability
J. Biol. Chem.,
December 23, 2005;
280(51):
42375 - 42382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Latorre, M. H. Roh, K. K. Frese, R. S. Weiss, B. Margolis, and R. T. Javier
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells
J. Cell Sci.,
September 15, 2005;
118(18):
4283 - 4293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Michel, J.-P. Arsanto, D. Massey-Harroche, C. Beclin, J. Wijnholds, and A. Le Bivic
PATJ connects and stabilizes apical and lateral components of tight junctions in human intestinal cells
J. Cell Sci.,
September 1, 2005;
118(17):
4049 - 4057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shin, S. Straight, and B. Margolis
PATJ regulates tight junction formation and polarity in mammalian epithelial cells
J. Cell Biol.,
February 28, 2005;
168(5):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vogelmann and W. J. Nelson
Fractionation of the Epithelial Apical Junctional Complex: Reassessment of Protein Distributions in Different Substructures
Mol. Biol. Cell,
February 1, 2005;
16(2):
701 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cereijido, R. G. Contreras, and L. Shoshani
Cell Adhesion, Polarity, and Epithelia in the Dawn of Metazoans
Physiol Rev,
October 1, 2004;
84(4):
1229 - 1262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bazzoni and E. Dejana
Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Physiol Rev,
July 1, 2004;
84(3):
869 - 901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Schneeberger and R. D. Lynch
The tight junction: a multifunctional complex
Am J Physiol Cell Physiol,
June 1, 2004;
286(6):
C1213 - C1228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Straight, K. Shin, V. C. Fogg, S. Fan, C.-J. Liu, M. Roh, and B. Margolis
Loss of PALS1 Expression Leads to Tight Junction and Polarity Defects
Mol. Biol. Cell,
April 1, 2004;
15(4):
1981 - 1990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ebnet, A. Suzuki, S. Ohno, and D. Vestweber
Junctional adhesion molecules (JAMs): more molecules with dual functions?
J. Cell Sci.,
January 1, 2004;
117(1):
19 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Roh and B. Margolis
Composition and function of PDZ protein complexes during cell polarization
Am J Physiol Renal Physiol,
September 1, 2003;
285(3):
F377 - F387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ben-Yosef, I. A. Belyantseva, T. L. Saunders, E. D. Hughes, K. Kawamoto, C. M. Van Itallie, L. A. Beyer, K. Halsey, D. J. Gardner, E. R. Wilcox, et al.
Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration
Hum. Mol. Genet.,
August 15, 2003;
12(16):
2049 - 2061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Roh, S. Fan, C.-J. Liu, and B. Margolis
The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells
J. Cell Sci.,
July 15, 2003;
116(14):
2895 - 2906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Knust and O. Bossinger
Composition and Formation of Intercellular Junctions in Epithelial Cells
Science,
December 6, 2002;
298(5600):
1955 - 1959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Poliak, S. Matlis, C. Ullmer, S. S. Scherer, and E. Peles
Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells
J. Cell Biol.,
October 28, 2002;
159(2):
361 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|